Sort
261,768 grants matching “gene therapy”
Function Of Skeletal Matrix Genes
$1,463,118Marian F Young · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE
The LUCINDA Trial
$1,463,084Tracy A. Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AG
Clinical Outcomes in Aicardi GoutiÃÂÃÂÃÂères Syndrome
$1,462,876Adeline Lucie Vanderver · Children'S Hosp Of Philadelphia · U01 · FY2020 · NS
Role of mouse microbiome in cancer and inflammation
$1,462,854Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Mechanical determinants of organ-selective metastatic colonization, dormancy and outgrowth
$1,462,791Roger D. Kamm · Massachusetts Institute Of Technology · U54 · FY2025 · CA
Functional Validation of TDP-43 splicing repression for frontotemporal degeneration
$1,462,754Philip C Wong · Johns Hopkins University · UG3 · FY2019 · NS
Molecular Therapeutics for Epithelial Disorders
$1,462,736Stanford University · P01 · FY2004 · AR
A blueprint for neutrophil heterogeneity and reprogramming in cancer
$1,462,500Chengcheng Jin · University Of Pennsylvania · DP2 · FY2022 · CA
HIV-1 Integrase
$1,462,355Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$1,462,168Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC
Muscular Dystrophy Cooperative Research Center
$1,462,151University Of Rochester · U54 · FY2004 · NS
Improved Diagnosis and Treatment of Cushing's Disease
$1,462,124Prashant Chittiboina · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Preclinical development of a novel therapeutic for Parkinson's disease
$1,461,860Aarash Bordbar · Sinopia Biosciences, Inc. · R44 · FY2023 · NS
EyeGENE: Creation of DNA Repository for Inherited Ophthalmic Diseases
$1,461,764Darby Thompson · The Emmes Company, Llc · N01 · FY2010 · EY
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer
$1,461,750Faraz Bishehsari · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
$1,461,713David E Fisher · Massachusetts General Hospital · P01 · FY2021 · CA
Muscular Dystrophy Cooperative Research Center
$1,461,638Richard T Moxley · University Of Rochester · U54 · FY2011 · NS
Immunotherapy of low grade lymphoid malignancies
$1,461,574Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,461,574Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Human Genes Affecting Chromosome Metabolism and Stress Response
$1,461,318Michael A Resnick · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Translational and clinical studies targeting y-globin modulation
$1,461,194David A Williams · Boston Children'S Hospital · U01 · FY2015 · HL
Effect of Network-Based Real Time Neurofeedback Augmentation of Mindfulness Practice on Recurrent Negative Thinking in Adolescents at Risk for Serious Mental Illness
$1,461,016A Eden Evins · Massachusetts General Hospital · R61 · FY2025 · MH
Overcoming resistance to BRAF(V600E) targeted therapies in melanoma
$1,460,954David E Fisher · Massachusetts General Hospital · P01 · FY2013 · CA
A Phase 1-2 clinical program for the teatment of Microsatellite Stable Colorectal Cancer with the combination of SR-8541A, Botensilimab, and Balstilimab
$1,460,952Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2025 · CA
National Brain and Tissue Resource for Parkinson's Disease and Related Disorders
$1,460,934Thomas G Beach · Banner Sun Health Research Institute · U24 · FY2011 · NS